106 related articles for article (PubMed ID: 27417255)
1. Impairment of oxidative phosphorylation increases the toxicity of SYD-1 on hepatocarcinoma cells (HepG2).
Brandt AP; Gozzi GJ; Pires Ado R; Martinez GR; Dos Santos Canuto AV; Echevarria A; Di Pietro A; Cadena SM
Chem Biol Interact; 2016 Aug; 256():154-60. PubMed ID: 27417255
[TBL] [Abstract][Full Text] [Related]
2. Sydnone SYD-1 affects the metabolic functions of isolated rat hepatocytes.
Brandt AP; Pires Ado R; Rocha ME; Noleto GR; Acco A; de Souza CE; Echevarria A; Canuto AV; Cadena SM
Chem Biol Interact; 2014 Jul; 218():107-14. PubMed ID: 24836382
[TBL] [Abstract][Full Text] [Related]
3. The toxicity of 1,3,4-thiadiazolium mesoionic derivatives on hepatocarcinoma cells (HepG2) is associated with mitochondrial dysfunction.
Pereira RA; Pires ADRA; Echevarria A; Sousa-Pereira D; Noleto GR; Suter Correia Cadena SM
Chem Biol Interact; 2021 Nov; 349():109675. PubMed ID: 34563518
[TBL] [Abstract][Full Text] [Related]
4. The antioxidant effect of the mesoionic compound SYD-1 in mitochondria.
Gozzi GJ; Pires Ado R; Martinez GR; Rocha ME; Noleto GR; Echevarria A; Canuto AV; Cadena SM
Chem Biol Interact; 2013 Oct; 205(3):181-7. PubMed ID: 23867904
[TBL] [Abstract][Full Text] [Related]
5. Effect of sydnone SYD-1, a mesoionic compound, on energy-linked functions of rat liver mitochondria.
Halila GC; de Oliveira MB; Echevarria A; Belém AC; Rocha ME; Carnieri EG; Martinez GR; Noleto GR; Cadena SM
Chem Biol Interact; 2007 Sep; 169(3):160-70. PubMed ID: 17644080
[TBL] [Abstract][Full Text] [Related]
6. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model.
Komulainen T; Lodge T; Hinttala R; Bolszak M; Pietilä M; Koivunen P; Hakkola J; Poulton J; Morten KJ; Uusimaa J
Toxicology; 2015 May; 331():47-56. PubMed ID: 25745980
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
[TBL] [Abstract][Full Text] [Related]
8. Effects of Phyllanthus urinaria extract on HepG2 cell viability and oxidative phosphorylation by isolated rat liver mitochondria.
Chudapongse N; Kamkhunthod M; Poompachee K
J Ethnopharmacol; 2010 Jul; 130(2):315-9. PubMed ID: 20488238
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma.
Dilip A; Cheng G; Joseph J; Kunnimalaiyaan S; Kalyanaraman B; Kunnimalaiyaan M; Gamblin TC
Anticancer Drugs; 2013 Oct; 24(9):881-8. PubMed ID: 23872912
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular toxicity of benzbromarone: effects on mitochondrial function and structure.
Felser A; Lindinger PW; Schnell D; Kratschmar DV; Odermatt A; Mies S; Jenö P; Krähenbühl S
Toxicology; 2014 Oct; 324():136-46. PubMed ID: 25108121
[TBL] [Abstract][Full Text] [Related]
11. The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism.
Rajasekaran R; Felser A; Nuoffer JM; Dufour JF; St-Pierre MV
FASEB J; 2018 Sep; 32(9):5143-5161. PubMed ID: 29913563
[TBL] [Abstract][Full Text] [Related]
12. MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics.
Yang Y; Nadanaciva S; Will Y; Woodhead JL; Howell BA; Watkins PB; Siler SQ
Pharm Res; 2015 Jun; 32(6):1975-92. PubMed ID: 25504454
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy.
Loiseau D; Morvan D; Chevrollier A; Demidem A; Douay O; Reynier P; Stepien G
Mol Carcinog; 2009 Aug; 48(8):733-41. PubMed ID: 19347860
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.
Luethi D; Liechti ME; Krähenbühl S
Toxicology; 2017 Jul; 387():57-66. PubMed ID: 28645576
[TBL] [Abstract][Full Text] [Related]
15. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
[TBL] [Abstract][Full Text] [Related]
16. Effects of new tetrahydroquinoline-isoxazole hybrids on bioenergetics of hepatocarcinoma Hep-G2 cells and rat liver mitochondria.
Álvarez Santos MR; Bueno Duarte Y; Güiza FM; Romero Bohórquez AR; Mendez-Sanchez SC
Chem Biol Interact; 2019 Apr; 302():164-171. PubMed ID: 30738022
[TBL] [Abstract][Full Text] [Related]
17. Global changes to HepG2 cell metabolism in response to galactose treatment.
Skolik RA; Solocinski J; Konkle ME; Chakraborty N; Menze MA
Am J Physiol Cell Physiol; 2021 May; 320(5):C778-C793. PubMed ID: 33439775
[TBL] [Abstract][Full Text] [Related]
18. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
19. Galactomannan from Schizolobium amazonicum seed and its sulfated derivatives impair metabolism in HepG2 cells.
Cunha de Padua MM; Suter Correia Cadena SM; de Oliveira Petkowicz CL; Martinez GR; Rodrigues Noleto G
Int J Biol Macromol; 2017 Aug; 101():464-473. PubMed ID: 28347788
[TBL] [Abstract][Full Text] [Related]
20. Selective Cytotoxicity of 1,3,4-Thiadiazolium Mesoionic Derivatives on Hepatocarcinoma Cells (HepG2).
Gozzi GJ; Pires Ado R; Valdameri G; Rocha ME; Martinez GR; Noleto GR; Acco A; Alves de Souza CE; Echevarria A; Moretto Dos Reis C; Di Pietro A; Suter Correia Cadena SM
PLoS One; 2015; 10(6):e0130046. PubMed ID: 26083249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
